This inventor holds 1 USPTO granted patent. Top assignee: Toyo Jozo Kabushiki Kaisha. Active years: 1988.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1988
Title: Katsumi Nishimura: Innovator in Blood Platelet Aggregation Inhibition
Introduction
Katsumi Nishimura is a notable inventor based in Shizuoka, Japan. He has made significant contributions to the field of medical science, particularly in the area of blood platelet aggregation. His innovative approach has the potential to impact the treatment of various cardiovascular conditions.
Latest Patents
Katsumi Nishimura holds a patent for a process aimed at inhibiting blood platelet aggregation and promoting vasodilation in humans. The patent describes a method that involves administering an effective amount of 2-hydroxy-3-isopropyl-5,6-dimethylpyrazine or its non-toxic salt to individuals in need. The administration can be done orally or parenterally, with specific dosage recommendations based on body weight.
Career Highlights
Throughout his career, Nishimura has been associated with Toyo Jozo Kabushiki Kaisha, where he has worked on various innovative projects. His dedication to research and development has led to advancements in medical treatments that could benefit many patients.
Collaborations
Katsumi Nishimura has collaborated with esteemed colleagues, including Masao Yaso and Noriyasu Takayanagi. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
Katsumi Nishimura's work in inhibiting blood platelet aggregation represents a significant advancement in medical science. His contributions have the potential to improve patient outcomes and enhance the understanding of cardiovascular health.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile